Deferred Tax Assets, Valuation Allowance of Anixa Biosciences Inc from 31 Oct 2012 to 31 Oct 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Anixa Biosciences Inc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Oct 2012 to 31 Oct 2024.
  • Anixa Biosciences Inc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Oct 2024 was $37,753,000,000.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Anixa Biosciences Inc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $37,753,000,000* +$37,718,498,000 31 Oct 2024 10-K 10 Jan 2025 2024 FY
Q3 2023 $34,502,000 +$4,900,000 +17% 31 Oct 2023 10-K 10 Jan 2025 2024 FY
Q3 2022 $29,602,000 +$1,321,000 +4.7% 31 Oct 2022 10-K 16 Jan 2024 2023 FY
Q3 2021 $28,281,000 -$475,000 -1.7% 31 Oct 2021 10-K 04 Jan 2023 2022 FY
Q3 2020 $28,756,000 +$396,000 +1.4% 31 Oct 2020 10-K 04 Jan 2022 2022 FY
Q3 2019 $28,360,000 +$1,943,000 +7.4% 31 Oct 2019 10-K 07 Jan 2021 2020 FY
Q3 2018 $26,417,000 +$2,990,000 +13% 31 Oct 2018 10-K 09 Jan 2020 2019 FY
Q3 2017 $23,427,000 -$16,886,000 -42% 31 Oct 2017 10-K 11 Jan 2019 2018 FY
Q3 2016 $40,313,000 +$1,765,000 +4.6% 31 Oct 2016 10-K 09 Jan 2018 2017 FY
Q3 2015 $38,548,000 +$888,000 +2.4% 31 Oct 2015 10-K 08 Dec 2016 2016 FY
Q3 2014 $37,660,000 +$7,783,000 +26% 31 Oct 2014 10-K 23 Dec 2015 2015 FY
Q3 2013 $29,877,000 +$2,486,000 +9.1% 31 Oct 2013 10-K 29 Jan 2015 2014 FY
Q3 2012 $27,391,000 31 Oct 2012 10-K/A 17 Jan 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.